Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) dropped 11.1% during mid-day trading on Friday . The company traded as low as $23.1050 and last traded at $23.1050. Approximately 800 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 857 shares. The stock had previously closed at $26.00.
Shionogi & Co., Ltd. Trading Down 11.1%
The firm has a fifty day moving average price of $18.46 and a 200 day moving average price of $17.69.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
Recommended Stories
- Five stocks we like better than Shionogi & Co., Ltd.
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
